By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Beta-blocker > Metoprolol

Metoprolol

GMJ
Last updated: 02/06/2026 14:31
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|644 words

Metoprolol: A Comprehensive Drug Profile

What is Metoprolol?

Metoprolol is a prescription medication belonging to a class of drugs called beta-blockers, specifically beta-1 selective adrenergic receptor antagonists. It is primarily used to treat high blood pressure, chest pain (angina), and heart failure, and to improve survival after heart attacks. This medication works by blocking certain stress hormones from affecting the heart and blood vessels.

Uses

Metoprolol has several FDA-approved medical uses:

  • Hypertension (High Blood Pressure): Helps lower blood pressure by reducing the heart’s workload and relaxing blood vessels
  • Angina Pectoris: Reduces chest pain by decreasing the heart’s oxygen demand during physical activity or stress
  • Heart Failure: Improves heart function and reduces symptoms in patients with chronic heart failure when used alongside other heart medications
  • Post-Heart Attack Treatment: Helps prevent future heart attacks and reduces mortality risk when started after a myocardial infarction
  • Arrhythmia Management: Sometimes prescribed off-label to help control irregular heart rhythms, particularly rapid heart rates

How it works

Metoprolol works by selectively blocking beta-1 adrenergic receptors, which are primarily found in heart tissue. When stress hormones like adrenaline try to bind to these receptors, metoprolol prevents this interaction, resulting in a slower heart rate and reduced force of heart contractions. This mechanism decreases the heart’s oxygen demand and reduces blood pressure, making it easier for the heart to pump blood efficiently throughout the body.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Fatigue and weakness
  • Dizziness or lightheadedness
  • Slow heart rate (bradycardia)
  • Cold hands and feet
  • Nausea or stomach upset
  • Headache
  • Sleep disturbances or unusual dreams
  • Decreased exercise tolerance

Serious side effects requiring immediate medical attention:

  • Severe shortness of breath or wheezing
  • Chest pain or irregular heartbeat
  • Swelling of hands, feet, or ankles
  • Sudden weight gain
  • Severe dizziness or fainting

Warnings and precautions

  • Asthma and COPD patients: Should use with extreme caution as beta-blockers can worsen breathing problems, even though metoprolol is beta-1 selective
  • Diabetes: May mask symptoms of low blood sugar and can affect glucose control; requires careful monitoring
  • Sudden discontinuation: Never stop taking metoprolol abruptly, as this can cause dangerous rebound effects including heart attack or severe high blood pressure
  • Pregnancy: Classified as pregnancy category C; should only be used when benefits outweigh potential risks to the fetus
  • Liver impairment: Patients with severe liver disease may need dose adjustments as metoprolol is metabolized in the liver

Interactions

Metoprolol can interact with numerous medications and substances:

  • Calcium channel blockers (verapamil, diltiazem): Can cause excessive lowering of heart rate and blood pressure
  • Digitalis glycosides: Combined use may lead to dangerous bradycardia and heart conduction problems
  • Insulin and diabetes medications: Beta-blockers can mask hypoglycemia symptoms and affect blood sugar control
  • NSAIDs (ibuprofen, naproxen): May reduce the blood pressure-lowering effects of metoprolol
  • CYP2D6 inhibitors (paroxetine, fluoxetine): Can increase metoprolol levels in the blood, enhancing effects and side effects
  • Clonidine: Simultaneous withdrawal of both drugs can cause dangerous blood pressure spikes
  • MAO inhibitors: May cause severe hypertensive reactions
  • Alcohol: Can enhance the blood pressure-lowering effects and increase dizziness

Check interactions with the GMJ Interaction Checker

Dosage

Metoprolol dosages vary significantly based on the condition being treated and individual patient factors. For hypertension, typical starting doses range from 25-50 mg twice daily for immediate-release formulations, with maintenance doses usually between 100-450 mg daily divided into two doses. Extended-release formulations are typically started at 25-100 mg once daily. For heart failure, treatment usually begins with very low doses (12.5-25 mg twice daily) and is gradually increased over several weeks. Post-heart attack treatment often starts at 25 mg twice daily, increasing as tolerated. All dosing must be individualized and determined by a healthcare provider based on patient response, other medical conditions, and concurrent medications.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Metoprolol." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/metoprolol/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Five Distinct Diabetes Development Patterns Identified Years Before Diagnosis

European study of 18,567 adults reveals five distinct metabolic pathways leading to…

Coeliac Disease Linked to Increased Death Risk and Cancer in Major US Study

Major US study of 60,000+ patients reveals coeliac disease patients face 39%…

Paralympic Doctor Returns to Sport as Blind Athlete with Guide Runner

Dr Oscar, a former Paralympic competitor turned medical professional, returns to sport…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Labetalol

By
Prof. Giorgi Pkhakadze
02/06/2026

Bisoprolol

By
Prof. Giorgi Pkhakadze
02/06/2026

Carvedilol

By
Prof. Giorgi Pkhakadze
02/06/2026

Nebivolol

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up